Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016
August 18 2016 - 5:30AM
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief
Executive Officer and Chairman of the Board, John Erb, is scheduled
to present at the 2016 investMNt Conference in Minneapolis, MN on
August 24th at 11:45 AM CT.
To access the live webcast, please visit the
Investors page of the Sunshine Heart website at
http://ir.sunshineheart.com/events.cfm. An audio archive of
the webcast will be available following the call on the Company’s
website.
About Sunshine HeartSunshine
Heart, Inc. (Nasdaq:SSH) is an early-stage medical device company
focused on developing a product portfolio to treat moderate to
severe heart failure and related conditions. Our objective is to
improve the quality of life for heart failure patients and halt the
disease progression. Sunshine Heart is a Delaware corporation
headquartered in Minneapolis with wholly owned subsidiaries in
Australia and Ireland. The Company has been listed on the NASDAQ
Capital Market since February 2012.
Forward-Looking StatementsCertain
statements in this release are forward-looking statements that are
based on management’s beliefs, assumptions, expectations, and
information currently available to management. All statements that
address future operating performance, events or developments that
we expect or anticipate will occur in the future are
forward-looking statements, including without limitation, clinical
and pre-clinical study designs and activities, expected timing for
initiation, enrollment and completion of clinical trials, research
and development activities, ultimate clinical outcomes and benefits
of our products to patients, design and development of future
studies, site activations, patient enrollment in studies, timing of
regulatory filings and approvals, regulatory acceptance of our
filings, our expectations with respect to product development and
commercialization efforts, market and physician acceptance of our
products, intellectual property protection, our ability to
integrate acquired businesses, our expectations regarding
anticipated synergies with and benefits from acquired businesses
and potentially competitive product offerings. The risk factors
described in our filings with the SEC could cause actual events to
adversely differ from the expectations indicated in these
forward-looking statements. Management believes that these
forward-looking statements are reasonable as and when made.
However, you should not place undue reliance on forward-looking
statements because they speak only as of the date when made.
Sunshine Heart does not assume any obligation to publicly update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise. Sunshine Heart may not
actually achieve the plans, projections or expectations disclosed
in forward-looking statements, and actual results, developments or
events could differ materially from those disclosed in the
forward-looking statements. Forward-looking statements are subject
to a number of risks and uncertainties, including without
limitation, the possibility that regulatory authorities do not
accept our application or approve the marketing of our therapy, the
possibility we may be unable to raise the funds necessary for the
development and commercialization of our therapy and other risks
and uncertainties described in our filings with the SEC. We do not
assume any obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
For further information, please contact:
Claudia Napal Drayton
Chief Financial Officer
Sunshine Heart, Inc.
T: +1-952-345-4205
Investor Relations
ir@sunshineheart.com
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Mar 2024 to Apr 2024
CHF Solutions (NASDAQ:CHFS)
Historical Stock Chart
From Apr 2023 to Apr 2024